Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Eltrombopag Olamine

Filters
×

filter

ELTROMBOPAG OLAMINE

filter

6280959*PED

7160870

7160870*PED

7332481

7332481*PED

7452874

7452874*PED

7473686

7473686*PED

7547719

7547719*PED

7790704

7790704*PED

7795293

7795293*PED

8052993

8052993*PED

8052994

8052994*PED

8062665

8062665*PED

8071129

8071129*PED

8828430

8828430*PED

filter

Y

Blank

filter

Y

Blank

filter

2019-04-30

2021-05-24

2021-11-24

2022-11-20

2023-05-20

2023-05-21

2023-11-21

2023-11-24

2025-07-13

2026-01-13

2027-08-01

2028-02-01

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8071129

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2026-01-13

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052994

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8071129*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-20

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052994*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-11-24

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1736

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7452874

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8062665*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8062665

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7452874

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8071129*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-20

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-11-21

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8828430

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-20

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052994*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8828430

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2026-01-13

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8828430*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-11-21

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8062665

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8071129

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052993

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-20

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052994

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-1736

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8062665

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-1736

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7452874*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-11-21

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8062665*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1575

Delist Requested

Application Number

22291

Patent Use Description

PATIENTS WITH SEVERE APLASTIC ANEMIA WHO HAVE HAD AN INSUFFICIENT RESPONSE TO IMMUNOSUPPRESSIVE THERAPY

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

6280959*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2019-04-30

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8828430*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1736

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8828430

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8071129

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8071129

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8062665*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2026-01-13

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8828430*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2026-01-13

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7452874

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052993*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

6280959*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2019-04-30

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8828430*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052993*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-02-01

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-2452

Delist Requested

Application Number

22291

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7452874*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2026-01-13

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

6280959*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2019-04-30

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052994

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052993

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-1736

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052993

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7790704

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7452874

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-1714

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7160870

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2022-11-20

Patent Use Code

U-1736

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN ADULT AND PEDIATRIC PATIENTS 1 YEAR AND OLDER WITH CHRONIC IMMUNE (IDIOPATHIC) THROMBOCYTOPENIA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8052994

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-2451

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

8062665

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2027-08-01

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-2452

Delist Requested

Application Number

207027

Patent Use Description

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-2452

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-2452

Delist Requested

Application Number

22291

Patent Use Description

Product Number

3

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2025-07-13

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7547719*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2026-01-13

Patent Use Code

Delist Requested

Application Number

207027

Patent Use Description

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-05-24

Patent Use Code

U-930

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7795293

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2023-05-21

Patent Use Code

U-1306

Delist Requested

Application Number

207027

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7332481

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-05-24

Patent Use Code

U-1306

Delist Requested

Application Number

22291

Patent Use Description

TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C TO ALLOW THE INITIATION AND MAINTENANCE OF INTERFERON-BASED THERAPY

Product Number

5

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7473686*PED

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-11-24

Patent Use Code

Delist Requested

Application Number

22291

Patent Use Description

Product Number

4